Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
The American Journal of Medicine
|
November 15, 2002
Effects of glycemic control and other determinants on vascular disease in type 2 diabetes
Burton E Sobel
Frontiers in Bioscience : a Journal and Virtual Library
|
September 6, 2003
Fibrinolysis and diabetes
Burton E Sobel
Coronary Artery Disease
|
March 24, 2010
Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial
Burton E Sobel
Coronary Artery Disease
|
October 4, 2012
On thwarting the seeds of scientific fraud
Burton E Sobel
The American Journal of Cardiology
|
July 4, 2006
Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities
Burton E Sobel,
Coronary Artery Disease
|
March 11, 2010
A perspective on the development of coronary revascularization
Burton E Sobel
The American Journal of Medicine
|
September 14, 2007
Optimizing cardiovascular outcomes in diabetes mellitus
Burton E Sobel
Diabetes Care
|
April 30, 2003
Coronary disease in type 1 diabetes: causal contiguity and clinical implications
Burton E Sobel
Diabetes Care
|
September 22, 2012
PAI-1 and diabetes: a journey from the bench to the bedside
David J Schneider, Burton E Sobel
Coronary Artery Disease
|
February 6, 2009
Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation
David J Schneider, Burton E Sobel
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
The American Journal of Medicine
|
November 15, 2002
Effects of glycemic control and other determinants on vascular disease in type 2 diabetes
Burton E Sobel
Frontiers in Bioscience : a Journal and Virtual Library
|
September 6, 2003
Fibrinolysis and diabetes
Burton E Sobel
Coronary Artery Disease
|
March 24, 2010
Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial
Burton E Sobel
Coronary Artery Disease
|
October 4, 2012
On thwarting the seeds of scientific fraud
Burton E Sobel
The American Journal of Cardiology
|
July 4, 2006
Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities
Burton E Sobel,
Coronary Artery Disease
|
March 11, 2010
A perspective on the development of coronary revascularization
Burton E Sobel
The American Journal of Medicine
|
September 14, 2007
Optimizing cardiovascular outcomes in diabetes mellitus
Burton E Sobel
Diabetes Care
|
April 30, 2003
Coronary disease in type 1 diabetes: causal contiguity and clinical implications
Burton E Sobel
Diabetes Care
|
September 22, 2012
PAI-1 and diabetes: a journey from the bench to the bedside
David J Schneider, Burton E Sobel
Coronary Artery Disease
|
February 6, 2009
Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation
David J Schneider, Burton E Sobel
Page
of 14